The company’s goal is to embed its technology in a wrist-worn device that can be used by anyone, not just diabetics, since continuous blood glucose monitoring has many applications in sports and weight management.
Quantune Technologies has raised €8.5M across 1 funding round from 2 investors, most recently a Seed round in Nov 2024. Based in Berlin, Germany; active in Deeptech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-11-12 | Seed | €8.5M |
| Point72 Ventures,Vsquared Ventures |
| View deal → |
